| CAS NO: | 133865-88-0 |
| 包装 | 价格(元) |
| 10mM (in 1mL DMSO) | 电议 |
| 10mg | 电议 |
| 50mg | 电议 |
| 100mg | 电议 |
| 200mg | 电议 |
| Cas No. | 133865-88-0 |
| 别名 | (S)-2-[[4-[(2-氟苄基)氧基]苄基]氨基]丙酰胺,FCE-26742A |
| Canonical SMILES | C[C@H](NCC1=CC=C(OCC2=CC=CC=C2F)C=C1)C(N)=O |
| 分子式 | C17H19FN2O2 |
| 分子量 | 302.34 |
| 溶解度 | DMSO: ≥ 125 mg/mL (413.44 mM) |
| 储存条件 | Store at -20°C |
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while. |
| Shipping Condition | Evaluation sample solution : ship with blue ice All other available size: ship with RT , or blue ice upon request |
| 产品描述 | Ralfinamide (FCE-26742A) is an orally available Na(+) channel blocker derived from α-aminoamide, with function of suppressing pain[1]. Sodium Channel[1] [1]. Zhang SH, et al. Ralfinamide administered orally before hindpaw neurectomy or postoperatively provided long-lasting suppression of spontaneous neuropathic pain-related behavior in the rat. Pain. 2008 Oct 15;139(2):293-305. [2]. Liang X, et al. Effects of ralfinamide in models of nerve injury and chemotherapy-induced neuropathic pain. Eur J Pharmacol. 2018 Mar 15;823:27-34. |
m.cnreagent.com